Switching from Metoprolol to Diltiazem in New Onset Atrial Fibrillation

Guideline-Based Equivalence

Both metoprolol and diltiazem are Grade 1B recommendations for rate control in atrial fibrillation, demonstrating equal efficacy for controlling heart rate both at rest and during exercise 1, 2, 3
The American Academy of Family Physicians and American College of Physicians explicitly list atenolol, metoprolol, diltiazem, and verapamil alphabetically by class without preference, indicating therapeutic equivalence 1, 2, 3
The European Society of Cardiology (2016) recommends non-dihydropyridine calcium channel blockers (diltiazem/verapamil) as preferred agents for acute rate control due to rapid onset of action and effectiveness at high sympathetic tone 4

Switch to diltiazem if there is inadequate rate control on metoprolol, as the European Society of Cardiology recommends switching to a non-dihydropyridine calcium channel blocker as first-line alternative for patients with preserved LVEF 5
Calcium channel blockers may be preferred over beta-blockers in patients with reactive airway disease, such as bronchospasm or chronic obstructive pulmonary disease 6
Switch to diltiazem if there are side effects from beta-blockade, such as lethargy, exercise intolerance, or excessive bradycardia at rest while tachycardic with activity 4

Do not switch to diltiazem if there is heart failure with reduced ejection fraction (LVEF <40%), as diltiazem and verapamil have negative inotropic effects and should be avoided in systolic dysfunction 4, 7, 8
Avoid switching to diltiazem in hemodynamic instability or acute decompensated heart failure, as beta-blockers or digoxin are preferred in this population 7, 6

Start diltiazem at standard dosing: 120-360 mg total daily dose (according to preparation) 4

Never use diltiazem in Wolff-Parkinson-White syndrome with pre-excited atrial fibrillation, as it facilitates anterograde conduction down the accessory pathway, risking ventricular fibrillation 7, 8
Avoid using diltiazem in acute heart failure with systolic dysfunction, and instead use beta-blockers, digoxin, or amiodarone 4, 7, 6
Don't forget anticoagulation, as rate control strategy does not eliminate stroke risk; maintain anticoagulation based on CHA₂DS₂-VASc score regardless of which rate-control agent is used 2, 3, 5